LABD vs. HIMS

Last updated Jun 24, 2026

LABD (Direxion Daily S&P Biotech Bear 3x Shares) is Leveraged Equities fund tracking the S&P Biotechnology Select Industry Index (-300%), while HIMS (Hims & Hers Health, Inc.) is a stock. Over the past 5 years, LABD returned -43.25%/yr vs 25.12%/yr for HIMS. At a correlation of -0.40, they often move in opposite directions.

Performance

LABD vs. HIMS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Hims & Hers Health, Inc. (HIMS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LABD achieves a -53.78% return, which is significantly lower than HIMS's 1.51% return.

LABD

• 1D: -3.10%
• 1M: -32.29%
• YTD: -53.78%
• 6M: -50.39%
• 1Y: -87.04%
• 3Y*: -56.99%
• 5Y*: -43.25%
• 10Y*: -59.09%

HIMS

• 1D: -1.73%
• 1M: 38.78%
• YTD: 1.51%
• 6M: -5.29%
• 1Y: -21.49%
• 3Y*: 57.60%
• 5Y*: 25.12%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LABD vs. HIMS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
LABD Direxion Daily S&P Biotech Bear 3x Shares	-53.78%	-70.07%	-21.43%	-41.77%	-32.68%	1.86%	-89.75%	-38.71%
HIMS Hims & Hers Health, Inc.	1.51%	34.28%	171.69%	38.85%	-2.14%	-55.14%	47.47%	1.23%

Correlation

The correlation between LABD and HIMS is -0.36, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.36
Correlation (3Y) Calculated over the trailing 3-year period	-0.39
Correlation (5Y) Calculated over the trailing 5-year period	-0.45
Correlation (All Time) Calculated using the full available price history since Sep 13, 2019	-0.40

Return for Risk

LABD vs. HIMS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABD

LABD Risk / Return Rank: 1
LABD Sharpe Ratio Rank: 1
LABD Sortino Ratio Rank: 0
LABD Omega Ratio Rank: 0
LABD Calmar Ratio Rank: 0
LABD Martin Ratio Rank: 2

HIMS

HIMS Risk / Return Rank: 35
HIMS Sharpe Ratio Rank: 33
HIMS Sortino Ratio Rank: 38
HIMS Omega Ratio Rank: 37
HIMS Calmar Ratio Rank: 34
HIMS Martin Ratio Rank: 35

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABD vs. HIMS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LABD	HIMS	Difference
Sharpe ratio: Return per unit of total volatility	-1.11	-0.24	-0.87
Sortino ratio: Return per unit of downside risk	-2.73	0.28	-3.01
Omega ratio: Gain probability vs. loss probability	0.70	1.03	-0.33
Calmar ratio: Return relative to maximum drawdown	-1.00	-0.28	-0.73
Martin ratio: Return relative to average drawdown	-1.37	-0.45	-0.93

LABD vs. HIMS - Sharpe Ratio Comparison

The current LABD Sharpe Ratio is -1.11, which is lower than the HIMS Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of LABD and HIMS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LABD vs. HIMS - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.99%, which is greater than HIMS's maximum drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for LABD and HIMS.

Drawdown Indicators

	LABD	HIMS	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-87.29%	-12.70%
Max Drawdown (1Y) Largest decline over 1 year	-86.75%	-78.06%	-8.69%
Max Drawdown (3Y) Largest decline over 3 years	-96.40%	-78.88%	-17.52%
Max Drawdown (5Y) Largest decline over 5 years	-98.65%	-78.88%	-19.77%
Max Drawdown (10Y) Largest decline over 10 years	-99.99%	—	—
Current Drawdown Current decline from peak	-99.99%	-52.05%	-47.94%
Average Drawdown Average peak-to-trough decline	-90.99%	-43.26%	-47.73%
Ulcer Index Depth and duration of drawdowns from previous peaks	64.00%	48.15%	+15.85%

Volatility

LABD vs. HIMS - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 29.98% compared to Hims & Hers Health, Inc. (HIMS) at 23.50%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LABD	HIMS	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.98%	23.50%	+6.48%
Volatility (6M) Calculated over the trailing 6-month period	65.23%	69.23%	-4.00%
Volatility (1Y) Calculated over the trailing 1-year period	78.79%	97.66%	-18.87%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	96.66%	83.58%	+13.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.97%	77.37%	+18.60%

Dividends

LABD vs. HIMS - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 9.79%, while HIMS has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
HIMS Hims & Hers Health, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LABD Direxion Daily S&P Biotech Bear 3x Shares	9.79%	6.67%	4.68%	6.13%	0.53%	0.00%	3.94%	1.75%	0.81%

Frequently Asked Questions

Can I hold both LABD and HIMS in my portfolio?

LABD and HIMS have a correlation of -0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LABD or HIMS?

LABD has higher volatility (29.98%) compared to HIMS (23.50%). In terms of maximum drawdown, LABD dropped -99.99% vs HIMS's -87.29%.

Which has better risk-adjusted returns?

HIMS currently has the higher Sharpe Ratio (-0.24 vs -1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.